Use of Mesenchymal Cellular Bone Matrix in Complex Cervical Surgery
Description
Featuring: Mark M. Mikhael, MD; Deepak Reddy, MD; Bradley Saitta, MD; Nick Shamie, MD
Disclosures:
Mikhael, Mark M.: Consulting: Clariance Spine (B), GS Medical (B).
Reddy, Deepak: Nothing to Disclose.
Saitta, Bradley: Nothing to Disclose.
Shamie, Nick: Royalties: Seaspine (B); Stock Ownership: SI Bone (100000 Shares, 1%), Vertiflex (200000 Shares, 1%); Consulting: Stryker (Financial, 0), Seaspine (Financial, 0), SI Bone (Financial, 0), Vertiflex (Financial, 0); Speaking and/or Teaching Arrangements: Medtronic (Financial, 0); Trips/Travel: Medtronic (Financial, 0); Board of Directors: Vertiflex (Financial, Medical Director); Scientific Advisory Board: SI Bone (Financial, Medical Advisory Board).
Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+
United States
